TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ACRS

Aclaris Therapeutics Inc

Healthcare · Biotechnology

5.20$ -4.3% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ACRS
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-0.72 -1.09 -1.62 -1.95 -3.06 -2.33 -0.91 -0.92 -1.04 -1.12 -0.26 -0.38
0.00 0.00 0.01 0.01 0.06 0.04 0.03 0.02 0.01 0.01 0.01 0.00
0.00 0.05 0.29 0.51 0.61 0.39 0.26 0.25 0.23 0.29 0.14 0.10
0.00 0.06 0.43 0.45 0.65 1.53 0.32 0.69 0.30 – – –
0.08 -0.06 0.20 0.03 0.29 -0.07 -0.06 -0.02 -0.02 0.13 0.14 0.02
0.04 0.03 0.01 0.04 0.04 0.04 0.01 0.01 0.01 0.02 0.00 0.00
-0.17 -4.13 -2.89 -1.98 0.28 2.56 0.15 -2.95 0.19 0.66 -0.90 0.39
– 0.00 0.00 0.00 – – 0.18 0.06 – – – –
5.94 5.18 5.46 3.57 3.06 0.01 0.18 -0.06 0.00 0.00 – 0.00
-0.01 0.00 0.00 0.00 0.89 -0.73 0.26 -0.20 0.00 0.00 – –
0.99 5.18 5.46 3.57 3.90 -0.73 0.43 3.97 1.12 0.38 0.96 -0.05
0.11 -0.05 0.95 -0.35 1.12 -0.51 -0.33 0.09 0.27 -0.08 -0.20 -0.04
-0.76 -1.12 -1.63 -1.99 -3.10 -2.37 -0.92 -0.92 -1.05 -1.14 -0.26 -0.38

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?